Day of Immunology Conference 2016: Immunotherapy for Cancer

Event Details

The Norwegian Society for Immunology is hosting their annual conference on the Day of Immunology on April 29. The theme for 2016 is Immunotherapy for Cancer and the event is open for any one interested in the theme. Please see program below or download program here and register at the bottom of this page.


Questions about the conference?

Take the opprtunity to get more information on immunology on: and

Morning session (popularized science in Norwegian)

10.00: Immun mot kreft? Introduksjon til kroppens overvåkningstjenester
Anne Spurkland, Professor, avdeling for molekylærmedisin, Universitet i Oslo

10.35: Immunterapi: en revolusjon for kreftbehandling (del I)
Else Marit Inderberg, PhD, avdeling for celleterapi, OUS Radiumhospitalet

10.55: Pause
11.15: Immunterapi: en revolusjon for kreftbehandling (del II)
Else Marit Inderberg, PhD, avdeling for celleterapi, OUS Radiumhospitalet

11.30: Behandling av norske lungekreftpasienter med checkpoint-inhibitorer
Åslaug Helland, overlege og forsker, avdeling for onkologi, OUS Radiumhospitalet

11.55: Immunterapi virker – rapport fra en erfaren pasient
Kjell Stenstadvold

12:10: Lunch break with refreshments

Afternoon session (scientific presentations made accessible for a broad public)
13.00: The long road to cancer vaccines
Gustav Gaudernack, Professor, OUS Radiumhospitalet

13.25: Targeting cancer stem cells in glioblastoma brain tumors by immunotherapy
Einar Vik-Mo, MD, PhD, Institute for Surgical Research and Department of Neurosurgery, OUS Rikshospitalet

13.50: Bringing innovative targeted DNA cancer vaccines to the clinic
Agnete Brunsvik Fredriksen, PhD, CSO, Vaccibody AS

14.05: Coffee break

14.30: Sequential Intranodal ImmunoTherapy (SIIT) in malignant lymphoma
Arne Kolstad, MD, PhD, Department of Oncology, OUS Radiumhospitalet

14.55: Clinical cellular immunotherapy at Radiumhospitalet
Gunnar Kvalheim, Professor, Head of Department of Cellular Therapy, OUS Radiumhospitalet.

15.20: From Bench to bedside with a first in class oncolytic peptide

Øystein Rekdal, PhD, Professor, The Arctic University of Norway, CSO, Lytix Biopharma AS


Chairperson: Alexandre Corthay, PhD, Department of Pathology, OUS, NSI president

Meeting’s organizers: The Norwegian Society for Immunology (NSI)

Oslo Cancer Cluster is sponsoring this event.



Print This Post